Back to Search
Start Over
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
- Source :
- The Journal of Allergy and Clinical Immunology: In Practice; 20240101, Issue: Preprints
- Publication Year :
- 2024
-
Abstract
- Biological therapies, such as mepolizumab, have transformed the treatment of severe eosinophilic asthma. Although mepolizumab’s short-term effectiveness is established, there is limited evidence on its ability to achieve long-term clinical remission.
Details
- Language :
- English
- ISSN :
- 22132198
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- The Journal of Allergy and Clinical Immunology: In Practice
- Publication Type :
- Periodical
- Accession number :
- ejs67238591
- Full Text :
- https://doi.org/10.1016/j.jaip.2024.08.033